enoxaparin sodium
Commercial- Indications
- Deep vein thrombosis, Pulmonary embolism
Company intelligence / Profile preview
The company manufactures commercial-scale polysaccharide APIs including enoxaparin sodium, heparin sodium/calcium, nadroparin calcium, dalteparin sodium. It also has a clinical-stage program with batroxobin injection currently in Phase I trials in China. The company has previously faced regulatory scrutiny but remains active and supplies globally.[1][2][3][5]
4 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dongying Tiandong Pharmaceutical Co., Ltd..